Investor Alert

Caribou Biosciences Inc.



After Hours

 --Quotes are delayed by 20 min

Dec 6, 2023, 7:51 p.m.





+0.29 +4.88%


Volume 205,263

Quotes are delayed by 20 min


Previous close

$ 5.71

$ 5.94


+0.23 +4.03%

Day low

Day high




52 week low

52 week high




Annual Financials for Caribou Biosciences Inc.


Fiscal year is January-December. All values USD millions. 2019202020212022 5-year trend
Cash & Short Term Investments -41.07M15.95M375.83M247.66M
Cash Only -41.07M15.95M240.42M58.34M
Short-Term Investments -----
Total Accounts Receivable -3.98M5.16M8.12M4.66M
Accounts Receivables, Net -841,0001.48M2.64M2.45M
Accounts Receivables, Gross -841,0001.48M2.64M2.45M
Bad Debt/Doubtful Accounts -----
Other Receivables -3.14M3.68M5.48M2.22M
Inventories -----
Finished Goods -----
Work in Progress -----
Raw Materials -----
Progress Payments & Other -----
Other Current Assets -11.96M3.19M7.24M7.92M
Miscellaneous Current Assets -8.77M760,000671,0001.12M
Total Current Assets -57.01M24.31M391.19M260.25M
2019202020212022 5-year trend
Net Property, Plant & Equipment -4.33M3.5M4.89M34.91M
Property, Plant & Equipment - Gross -6.59M6.6M8.96M40.56M
Buildings -----
Land & Improvements -----
Computer Software and Equipment -261,000263,000273,000709,000
Other Property, Plant & Equipment -1.26M1.3M1.83M2.04M
Accumulated Depreciation -2.26M3.1M4.08M5.65M
Total Investments and Advances --7.63M45.4M77.07M
Other Long-Term Investments --7.63M45.4M77.07M
Long-Term Note Receivable -----
Intangible Assets -----
Net Goodwill -----
Net Other Intangibles -----
Other Assets -593,000612,000875,0001.54M
Tangible Other Assets -593,000612,000875,0001.54M
Total Assets -61.93M38.53M445.2M384.27M

Liabilities & Shareholders' Equity

2019202020212022 5-year trend
ST Debt & Current Portion LT Debt -532,000847,000259,000966,000
Short Term Debt -532,000193,000259,000966,000
Current Portion of Long Term Debt --654,000--
Accounts Payable -2.54M2.6M3.99M1.15M
Income Tax Payable -11,0005,000--
Other Current Liabilities -7M8.94M21.58M26.02M
Dividends Payable -----
Accrued Payroll -400,0002.08M4.23M-
Miscellaneous Current Liabilities -6.6M6.86M17.36M26.02M
Total Current Liabilities -10.08M12.39M25.83M28.13M
Long-Term Debt -41.32M42.25M-26.78M
Long-Term Debt excl. Capitalized Leases -41.32M42.25M--
Non-Convertible Debt -41.32M42.25M--
Convertible Debt -----
Capitalized Lease Obligations -----
Provision for Risks & Charges -----
Deferred Taxes -650,000155,000476,000381,000
Deferred Taxes - Credit -650,0002.64M3.32M10.88M
Deferred Taxes - Debit --2.48M2.85M10.5M
Other Liabilities -2.42M4.69M28.23M17.61M
Other Liabilities (excl. Deferred Income) -1.43M3.76M6.19M1.65M
Deferred Income -986,000937,00022.03M15.95M
Total Liabilities -54.47M61.97M57.38M83.4M
Non-Equity Reserves -----
Preferred Stock (Carrying Value) -----
Redeemable Preferred Stock -----
Non-Redeemable Preferred Stock -----
Common Equity (Total) -7.46M(23.44M)387.83M300.87M
Common Stock Par/Carry Value -1,0001,0006,0006,000
Retained Earnings -3.44M(30.87M)(97.79M)(197.22M)
ESOP Debt Guarantee -----
Cumulative Translation Adjustment/Unrealized For. Exch. Gain -----
Unrealized Gain/Loss Marketable Securities ---(135,000)(1.52M)
Revaluation Reserves -----
Treasury Stock -----
Total Shareholders' Equity -7.46M(23.44M)387.83M300.87M
Accumulated Minority Interest -----
Total Equity -7.46M(23.44M)387.83M300.87M
Liabilities & Shareholders' Equity -61.93M38.53M445.2M384.27M
Link to MarketWatch's Slice.